| 000 | 01649 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518091508.0 | ||
| 264 | 0 | _c20210706 | |
| 008 | 202107s 0 0 eng d | ||
| 022 | _a1479-7364 | ||
| 024 | 7 |
_a10.1186/s40246-020-00260-w _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrocker, Chad N | |
| 245 | 0 | 0 |
_aMetabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. _h[electronic resource] |
| 260 |
_bHuman genomics _c03 2020 |
||
| 300 |
_a10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacteria _xdrug effects |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGastrointestinal Microbiome |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolome _xdrug effects |
| 650 | 0 | 4 |
_aMetoprolol _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aUrinalysis _xmethods |
| 700 | 1 | _aVelenosi, Thomas | |
| 700 | 1 | _aFlaten, Hania K | |
| 700 | 1 | _aMcWilliams, Glenn | |
| 700 | 1 | _aMcDaniel, Kyle | |
| 700 | 1 | _aShelton, Shelby K | |
| 700 | 1 | _aSaben, Jessica | |
| 700 | 1 | _aKrausz, Kristopher W | |
| 700 | 1 | _aGonzalez, Frank J | |
| 700 | 1 | _aMonte, Andrew A | |
| 773 | 0 |
_tHuman genomics _gvol. 14 _gno. 1 _gp. 10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s40246-020-00260-w _zAvailable from publisher's website |
| 999 |
_c30731312 _d30731312 |
||